Last reviewed · How we verify
Fenfuro
At a glance
| Generic name | Fenfuro |
|---|---|
| Also known as | Fenugreek seed extract |
| Sponsor | Chemical Resources |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes (NA)
- Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study (PHASE4)
- Evaluation of Fenugreek Seed Extract In Type- 2 Diabetes: An Add-On Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fenfuro CI brief — competitive landscape report
- Fenfuro updates RSS · CI watch RSS
- Chemical Resources portfolio CI